|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.730 USD | +1.97% |
|
+62.17% | +205.91% |
| Dec. 07 | Immix Biopharma prices offering of 19.1 million shares at $5.10 per share | RE |
| Nov. 12 | Immix Biopharma, Inc. Appoints Michael Grabow as Chief Commercial Officer | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -8.52x | - | -4.31x | - | -8.88x | -8.66x | - | 226M | |
| 49.75x | 8.12x | 1.93x | 12.14x | 43.64x | 44.96x | -.--% | 54.9B | |
| -31.5x | 62.94x | -2.95x | 79.91x | -35.32x | -34.79x | -.--% | 40.49B | |
| 16.31x | 3.85x | 0.22x | 5.72x | 12.97x | 14.99x | 1.74% | 39.05B | |
| -25.44x | 1.1x | -1.51x | 3.37x | -9.87x | -7.52x | -.--% | 23.02B | |
| 17.18x | 3.26x | -4.81x | 4.22x | 11.22x | 11.93x | -.--% | 19.13B | |
| 28.27x | 2.61x | 0.74x | 5.56x | 15.41x | 19.19x | -.--% | 17.81B | |
| -493.4x | 13.52x | 7.78x | 28.5x | 672.01x | -573.17x | -.--% | 13.83B | |
| -13.21x | - | -0.04x | 165.76x | -25.85x | -12.87x | -.--% | 13.83B | |
| -182.69x | 22.07x | -2.24x | 44.91x | -179.17x | -155.17x | -.--% | 12.35B | |
| -56.46x | 20.84x | 1.02x | 12.67x | -53.71x | -48.42x | -.--% | 12.55B | |
| 16.43x | 4.31x | 0.37x | 4.58x | 11.36x | 12.77x | -.--% | 11.06B | |
| -20.84x | 17.29x | -0x | 21.03x | -32.58x | -20.45x | -.--% | 9.35B | |
| -18.35x | 8.71x | -0.4x | - | -18.88x | -18.24x | -.--% | 8.21B | |
| -9.75x | -14.88x | -0.48x | 84.89x | -11.91x | -11.66x | -.--% | 7.37B | |
| -16.45x | 12.85x | -0.22x | 125.66x | -19.12x | -18.61x | -.--% | 7.34B | |
| Average | -46.79x | 11.90x | -0.31x | 42.78x | 23.21x | -50.36x | 0.12% | 18.16B | |
| Weighted average by Cap. | -27.50x | 15.43x | -0.11x | 33.96x | 24.84x | -31.01x | 0.23% |
- Stock Market
- Equities
- IMMX Stock
- Sector Immix Biopharma, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
